Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Qiuju Sheng"'
Publikováno v:
Platelets, Vol 33, Iss 2, Pp 212-218 (2022)
Hepatitis B virus (HBV) is a kind of hepatotropic DNA virus. The main target organ is liver, except for liver, HBV has been found in a variety of extrahepatic tissues, such as kidney, thyroid, pancreas, bone marrow, etc. HBV can cause severe complica
Externí odkaz:
https://doaj.org/article/f8e357ea5f6b4c2794d5f81cf60a92ed
Autor:
Xiaoqiong Duan, Xiao Liu, Wenting Li, Jacinta A. Holmes, Annie J. Kruger, Chunhui Yang, Yujia Li, Min Xu, Haiyan Ye, Shuang Li, Xinzhong Liao, Qiuju Sheng, Dong Chen, Tuo Shao, Zhimeng Cheng, Batul Kaj, Esperance A. Schaefer, Shilin Li, Limin Chen, Wenyu Lin, Raymond T. Chung
Publikováno v:
Cells, Vol 8, Iss 4, p 338 (2019)
We previously identified that miR-130a downregulates HCV replication through two independent pathways: restoration of host immune responses and regulation of pyruvate metabolism. In this study, we further sought to explore host antiviral target genes
Externí odkaz:
https://doaj.org/article/e3c3c94c9e124170b656e071ce406e42
Autor:
Wenting Li, Xiaoqiong Duan, Chuanlong Zhu, Xiao Liu, Andre J. Jeyarajan, Min Xu, Zeng Tu, Qiuju Sheng, Dong Chen, Chuanwu Zhu, Tuo Shao, Zhimeng Cheng, Shadi Salloum, Esperance A. Schaefer, Annie J. Kruger, Jacinta A. Holmes, Raymond T. Chung, Wenyu Lin
Publikováno v:
J Immunol
Hepatitis B virus (HBV)/hepatitis C virus (HCV) coinfection accelerates liver fibrosis progression compared with HBV or HCV monoinfection. Octamer binding transcription factor 4 (OCT4) and Nanog are direct targets of the profibrogenic TGF-β1 signali
Publikováno v:
Platelets. 33:212-218
Hepatitis B virus (HBV) is a kind of hepatotropic DNA virus. The main target organ is liver, except for liver, HBV has been found in a variety of extrahepatic tissues, such as kidney, thyroid, pancreas, bone marrow, etc. HBV can cause severe complica
Autor:
Lin Wang, Yang Ding, Yanwei Li, Bingchao Lu, Qiuju Sheng, Yaoxin Fan, Xiaoguang Dou, Chao Han, Chong Zhang
Publikováno v:
Journal of Cancer
Background: Long noncoding RNAs (lncRNAs) have emerged as gene regulators in various cancers, including hepatocellular carcinoma (HCC). However, the biological roles and mechanisms of many lncRNAs in HCC tumorigenesis remain unknown. Aim: To identify
Autor:
Yaoxin Fan, Pingping Lai, Yanwei Li, Chong Zhang, Qiuju Sheng, Wenyue Tian, Chao Han, Xiaoguang Dou, Yang Ding
Publikováno v:
World Journal of Gastrointestinal Oncology
BACKGROUND The exact regulation network of programmed death 1 (PD-1), programmed death ligand 1 (PD-L1), and programmed death ligand 2 (PD-L2) signaling in immune escape is largely unknown. We aimed to describe the gene expression profiles related to
Publikováno v:
World Journal of Clinical Cases
Background Undifferentiated embryonal sarcoma of the liver (UESL) is a rare liver malignancy originating from primary mesenchymal tissue. The clinical manifestations, laboratory tests, and imaging examinations of the disease lack specificity and the
Autor:
Xiaoguang Dou, Yang Ding, Yanwei Li, Chao Han, Chong Zhang, Lin Wang, Qiuju Sheng, Yaoxin Fan
Publikováno v:
Aging (Albany NY)
Liver stiffness measurement (LSM) frequently overestimates the severity of liver fibrosis because of steatosis. However, the impact of the controlled attenuation parameter (CAP) on liver stiffness cutoff values remains unknown; CAP was used to quanti
Autor:
Leyu Zheng, Xiaoguang Dou, Lianrong Zhao, Yuanyuan Jin, Yurong Li, Weijia Zhu, Ziying An, Qiuju Sheng, Jingyan Wang, Nan Geng, Han Bai
Publikováno v:
Viral Immunology. 33:99-104
The prevalence of hepatitis B virus (HBV) infection was an imbalance in different provinces of China. This study aimed to investigate the prevalence of HBV infection and evaluate the prophylactic measures in a public hospital of northeast China over
Autor:
Chao Han, Ziyi Wang, Xiaoguang Dou, Yanwei Li, Zhengrong Yang, Chong Zhang, Yang Ding, Qiuju Sheng
Publikováno v:
International Journal of Medical Sciences
Objective: The proportion of hepatitis e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients in China has increased rapidly. However, the response of these patients to peginterferon (peg-IFN) treatment is poor, and the antiviral treatment str